Merck on Tuesday posted a 10.4% rise in first-quarter profit, helped by strong sales of cancer therapy Keytruda, but the drugmaker lowered its 2020 profit forecast due to uncertainty from the Covid-19 pandemic.
from Earnings https://ift.tt/2KHjqaE
via IFTTT
No comments:
Post a Comment